Immunotherapy with inactivated fluorouracil-treated CT-26 cells plus granulocyte-macrophage colony-stimulating factor produces a therapeutic effect in a CT-26 colon cancer mouse model. This evidence concerns the gene CSF2 and malignant colon neoplasm.